Skip to content
10-K

Annual Report

ENTERA BIO LTD. ENTX

0001178913-26-001797

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 23, 2026 46.62M sh
Shares Diluted FY 2025 · Dec 31, 2025 46.19M sh
Shares Diluted FY 2025 · Dec 31, 2024 37.65M sh
Capex FY 2025 · Dec 31, 2025 $107K
Capex FY 2025 · Dec 31, 2024 $3K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$7.37M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$6.82M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.11M
Cash And Equivalents FY 2025 · Dec 31, 2024 $8.66M
Stockholders Equity FY 2025 · Dec 31, 2025 $13.1M
Stockholders Equity FY 2025 · Dec 31, 2024 $8.08M
Stockholders Equity FY 2025 · Dec 31, 2023 $10.39M
Current Liabilities FY 2025 · Dec 31, 2025 $2.2M
Current Liabilities FY 2025 · Dec 31, 2024 $1.18M
Total Liabilities FY 2025 · Dec 31, 2025 $2.89M
Total Liabilities FY 2025 · Dec 31, 2024 $1.31M
Current Assets FY 2025 · Dec 31, 2025 $15.3M
Current Assets FY 2025 · Dec 31, 2024 $8.97M
Total Assets FY 2025 · Dec 31, 2025 $15.99M
Total Assets FY 2025 · Dec 31, 2024 $9.39M
Eps Diluted FY 2025 · Dec 31, 2025 $0.25
Eps Diluted FY 2025 · Dec 31, 2024 $0.25
Eps Basic FY 2025 · Dec 31, 2025 $0.25
Eps Basic FY 2025 · Dec 31, 2024 $0.25
Sga Expense FY 2025 · Dec 31, 2025 $398K
Sga Expense FY 2025 · Dec 31, 2024 $340K
Rd Expense FY 2025 · Dec 31, 2025 $6M
Rd Expense FY 2025 · Dec 31, 2024 $4.5M
Net Income FY 2025 · Dec 31, 2025 −$11.44M
Net Income FY 2025 · Dec 31, 2024 −$9.54M
Operating Income FY 2025 · Dec 31, 2025 −$11.53M
Operating Income FY 2025 · Dec 31, 2024 −$9.59M
Gross Profit FY 2025 · Dec 31, 2025 $0
Gross Profit FY 2025 · Dec 31, 2024 $9K
Cost Of Revenue FY 2025 · Dec 31, 2025 $42K
Cost Of Revenue FY 2025 · Dec 31, 2024 $172K
Revenue FY 2025 · Dec 31, 2025 $42K
Revenue FY 2025 · Dec 31, 2024 $181K